Premium
A technological and regulatory outlook on CRISPR crop editing
Author(s) -
Globus Rea,
Qimron Udi
Publication year - 2018
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.26303
Subject(s) - crispr , biosafety , genome editing , microbiology and biotechnology , genetically modified crops , genetically modified organism , biology , biochemical engineering , risk analysis (engineering) , business , gene , engineering , genetics , transgene
Abstract Generating plants with increased yields while maintaining low production and maintenance costs is highly important since plants are the major food source for humans and animals, as well as important producers of chemicals, pharmaceuticals, and fuels. Gene editing approaches, particularly the CRISPR‐Cas system, are the preferred methods for improving crops, enabling quick, robust, and accurate gene manipulation. Nevertheless, new breeds of genetically modified crops have initiated substantial debates concerning their biosafety, commercial use, and regulation. Here, we discuss the challenges facing genetic engineering of crops by CRISPR‐cas, and highlight the pros and cons of using this tool.